Aberdeen Group plc bought a new stake in shares of Doximity, Inc. (NYSE:DOCS – Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 435,026 shares of the company’s stock, valued at approximately $12,329,000.
Several other institutional investors and hedge funds have also bought and sold shares of DOCS. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Doximity in the third quarter worth $45,000. Versant Capital Management Inc raised its holdings in shares of Doximity by 1,176.9% during the third quarter. Versant Capital Management Inc now owns 1,826 shares of the company’s stock valued at $52,000 after purchasing an additional 1,683 shares during the period. Nisa Investment Advisors LLC raised its holdings in shares of Doximity by 59.9% during the third quarter. Nisa Investment Advisors LLC now owns 1,855 shares of the company’s stock valued at $53,000 after purchasing an additional 695 shares during the period. Parallel Advisors LLC boosted its position in shares of Doximity by 111.0% during the 1st quarter. Parallel Advisors LLC now owns 2,560 shares of the company’s stock worth $60,000 after purchasing an additional 1,347 shares in the last quarter. Finally, Fortitude Family Office LLC boosted its position in shares of Doximity by 31,271.4% during the 3rd quarter. Fortitude Family Office LLC now owns 2,196 shares of the company’s stock worth $62,000 after purchasing an additional 2,189 shares in the last quarter. 87.19% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research analysts recently weighed in on the company. Barclays upped their price target on Doximity from $27.00 to $30.00 and gave the stock an “equal weight” rating in a research note on Wednesday, November 11th. Raymond James Financial reissued an “outperform” rating and issued a $38.00 price objective on shares of Doximity in a research note on Friday, October 16th. Freedom Capital lowered Doximity from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 8th. Evercore set a $35.00 target price on Doximity in a report on Tuesday, September 29th. Finally, Royal Bank Of Canada lifted their price target on shares of Doximity from $28.00 to $34.00 and gave the company an “outperform” rating in a research report on Friday, November 6th. Eight investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $30.59.
Insider Transactions at Doximity
In other news, Director Kira Wampler sold 2,000 shares of Doximity stock in a transaction dated Monday, November 2nd. The shares were sold at an average price of $32.89, for a total value of $65,780.00. Following the completion of the transaction, the director owned 27,923 shares in the company, valued at $918,387.47. This trade represents a 6.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Siddharth Sitaram sold 2,523 shares of the business’s stock in a transaction that occurred on Monday, November 16th. The shares were sold at an average price of $33.31, for a total transaction of $84,041.13. Following the completion of the sale, the chief accounting officer directly owned 104,085 shares in the company, valued at approximately $3,467,071.35. This trade represents a 2.37% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 25,224 shares of company stock valued at $801,442. 31.80% of the stock is currently owned by insiders.
Doximity Trading Down 1.1%
Shares of NYSE DOCS opened at $30.75 on Thursday. The stock has a fifty day simple moving average of $30.13 and a two-hundred day simple moving average of $25.23. Doximity, Inc. has a 1-year low of $17.15 and a 1-year high of $51.85. The firm has a market cap of $5.49 billion, a price-to-earnings ratio of 40.40, a price-to-earnings-growth ratio of 33.31 and a beta of 1.29.
Doximity (NYSE:DOCS – Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The company reported $0.36 EPS for the quarter, beating analysts’ consensus estimates of $0.19 by $0.17. The firm had revenue of $174.54 million for the quarter. Doximity had a return on equity of 15.80% and a net margin of 21.12%. The firm’s quarterly revenue was up 3.6% on a year-over-year basis. During the same period in the prior year, the company earned $0.45 EPS. Analysts forecast that Doximity, Inc. will post 0.72 EPS for the current year.
About Doximity
Doximity, Inc. operates a digital platform designed for medical professionals, including physicians and other clinicians. Its services support professional networking, medical news and research discovery, career development, and communication among healthcare professionals. The company also offers clinical workflow tools, including Doximity Dialer, which enables clinicians to make calls and conduct video visits using a work number, as well as digital fax and document services. Doximity provides marketing and recruitment solutions to healthcare organizations and life sciences companies.
See Also
- Five stocks we like better than Doximity
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NYSE:DOCS – Free Report).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
